Search research articles
Contact Us
Filters
Showing results (111-120 of 156) with videos related to
Page
of 16
Sort By:
British Journal of Cancer
|
June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites
M R Stratford, G J Rustin, M F Dennis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1997
POMB/ACE chemotherapy for mediastinal germ cell tumours
M Bower, C Brock, L Holden, et al.
Clinical Radiology
|
May 1, 1987
Surgery, chemotherapy and whole abdominal radiotherapy in the management of advanced ovarian carcinoma
G J Rustin, M Minton, B Southcott, et al.
British Journal of Cancer
|
November 1, 1984
Response of differentiated but not anaplastic teratoma to interferon
G J Rustin, S B Kaye, C J Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma
P A Philip, G J Rustin, J A Ledermann, et al.
The International Journal of Biological Markers
|
January 1, 1989
Carcinoembryonic antigen levels in germ cell tumours
R N Hitchins, G J Rustin, H D Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel
J A Bridgewater, A E Nelstrop, G J Rustin, et al.
British Journal of Cancer
|
February 1, 1989
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis
R N Hitchins, E S Newlands, D B Smith, et al.
British Journal of Cancer
|
November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer
D J Kerr, G J Rustin, S B Kaye, et al.
British Journal of Urology
|
August 1, 1994
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours
J A Ledermann, L Holden, E S Newlands, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 156) with videos related to
Sort By:
Page
of 16
British Journal of Cancer
|
June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites
M R Stratford, G J Rustin, M F Dennis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 1997
POMB/ACE chemotherapy for mediastinal germ cell tumours
M Bower, C Brock, L Holden, et al.
Clinical Radiology
|
May 1, 1987
Surgery, chemotherapy and whole abdominal radiotherapy in the management of advanced ovarian carcinoma
G J Rustin, M Minton, B Southcott, et al.
British Journal of Cancer
|
November 1, 1984
Response of differentiated but not anaplastic teratoma to interferon
G J Rustin, S B Kaye, C J Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma
P A Philip, G J Rustin, J A Ledermann, et al.
The International Journal of Biological Markers
|
January 1, 1989
Carcinoembryonic antigen levels in germ cell tumours
R N Hitchins, G J Rustin, H D Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel
J A Bridgewater, A E Nelstrop, G J Rustin, et al.
British Journal of Cancer
|
February 1, 1989
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis
R N Hitchins, E S Newlands, D B Smith, et al.
British Journal of Cancer
|
November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer
D J Kerr, G J Rustin, S B Kaye, et al.
British Journal of Urology
|
August 1, 1994
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours
J A Ledermann, L Holden, E S Newlands, et al.
Page
of 16